Profile data is unavailable for this security.
About the company
SMAIO SA is a France-based company that specializes in the design, manufacture and marketing of implantable medical devices for the treatment of spinal pathologies. The Company provides control on a surgical procedure to spine physician through a wide range of solutions like surgical plan/ i-plan, surgical procedure i-perform, outcome data/ i-check, and education/ i-learn. It operates with the clinical data and imaging for specialists in spine surgery for transformation of the vertebral fusion. It also offers spine surgeons a complete solution, consisting of software, implantable devices, associated services, and treat spinal pathologies requiring surgery. It includes Kheiron Spinal Fixation System, a device that incorporates many implants, intended for the immobilization and stabilization of spinal segments as an adjunct to fusion of the thoracic, lumbar and/or sacral spine. It also develops the Keops and Balance Analyzer 3D surgical planning and patient database management software.
- Revenue in EUR (TTM)8.28m
- Net income in EUR-1.85m
- Incorporated2009
- Employees43.00
- LocationSMAIO SA2 Place Berthe MorisotParc TechnologiqueSAINT-PRIEST 69800FranceFRA
- Phone+33 469842302
- Fax+33 428292118
- Websitehttps://smaio.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medico Remedies Ltd | 15.88m | 1.05m | 37.01m | 213.00 | 34.94 | 5.99 | 27.83 | 2.33 | 1.38 | 1.38 | 20.86 | 8.06 | 1.45 | 4.24 | 3.16 | 8,060,085.00 | 9.60 | 7.65 | 18.41 | 14.77 | 27.88 | 24.48 | 6.61 | 4.87 | 1.03 | 9.55 | 0.1578 | -- | 4.15 | 11.23 | 21.74 | 44.00 | -0.8645 | -- |
| Amanta Healthcare Ltd | -924.80m | -924.80m | 38.08m | 506.00 | -- | 1.95 | -- | -- | -- | -- | -- | 54.26 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.34 | -- | 0.4687 | -- | -2.01 | -- | 189.02 | -- | -- | -- |
| SMAIO SA | 8.28m | -1.85m | 38.95m | 43.00 | -- | 5.25 | -- | 4.70 | -0.3498 | -0.3498 | 1.55 | 1.31 | 0.6265 | 0.9214 | 7.47 | 202,030.50 | -14.00 | -10.92 | -17.52 | -20.23 | 83.83 | 83.68 | -22.35 | -31.59 | 2.50 | -32.37 | 0.288 | -- | 2.12 | 69.74 | -426.41 | -- | 16.09 | -- |
| Nippon Chemiphar Co Ltd | 175.09m | 2.93m | 39.46m | 855.00 | 11.39 | 0.324 | 3.58 | 0.2254 | 151.00 | 151.00 | 9,009.80 | 5,309.46 | 0.6233 | 1.98 | 2.75 | 38,035,090.00 | 1.04 | 0.6794 | 1.44 | 0.9686 | 26.19 | 28.43 | 1.68 | 1.04 | 1.34 | -- | 0.4785 | 55.16 | 5.93 | 0.5075 | 263.33 | -7.58 | 32.85 | 0.00 |
| RTA Lbrtvrlr Byljk rnlr lc v Mkn Sny Tcr | 3.78m | 7.46m | 39.67m | 61.00 | 5.32 | 0.881 | 4.97 | 10.50 | 0.775 | 0.775 | 0.3923 | 4.68 | 0.0931 | 3.20 | 3.03 | 2,928,819.00 | 18.39 | 5.86 | 19.57 | 6.97 | 34.50 | 36.26 | 197.52 | 26.39 | 1.57 | -- | 0.0317 | -- | 14.50 | 56.74 | 150.63 | 63.85 | 78.83 | -- |
| Corline Biomedical AB | 711.10k | -2.24m | 39.88m | 13.00 | -- | 5.25 | -- | 56.08 | -1.02 | -1.02 | 0.3142 | 3.15 | 0.0862 | -- | 10.59 | 581,461.60 | -27.20 | -8.36 | -29.49 | -9.10 | 82.54 | 121.50 | -315.49 | -53.37 | -- | -1,153.67 | 0.00 | -- | -60.95 | 55.82 | -1,182.15 | -- | 9.13 | -- |
| LSL Pharma Group Inc | 16.59m | 1.72m | 40.42m | -- | 21.66 | 2.48 | 12.97 | 2.44 | 0.024 | 0.024 | 0.2307 | 0.2094 | 0.5462 | 1.98 | 5.78 | -- | 5.65 | -- | 7.29 | -- | 29.73 | -- | 10.35 | -- | 0.5366 | 0.6521 | 0.5325 | -- | 76.98 | -- | 139.15 | -- | -- | -- |
| Nasus Pharma Ltd | 0.00 | -1.00m | 40.85m | -- | -- | -- | -- | -- | -0.1319 | -0.1383 | 0.00 | -0.4762 | 0.00 | -- | -- | -- | -373.32 | -- | -- | -- | -- | -- | -- | -- | -- | -2.51 | -- | -- | -- | -- | -54.23 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| MCA Finance SAas of 31 Dec 2024 | 149.28k | 2.64% |
